Is CALT or RYLD a better dividend investment in 2026?

CALT currently yields 5.00% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between CALT and RYLD?

CALT has a forward dividend yield of 5.00% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 7.14 percentage points.

Home › Compare › CALT vs RYLD

CALT vs RYLD: Dividend Comparison 2026

CALT yields 5.00% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $16.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CALT

● Live price

5.00%

Share price

$40.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$688.45

Full CALT calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — CALT vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CALT	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CALT + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CALT pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CALT

Annual income on $10K today (after 15% tax)

$425.00/yr

After 10yr DRIP, annual income (after tax)

$585.18/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $1,614.07/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CALT + RYLD for your $10,000?

CALT: 50%RYLD: 50%

100% RYLD50/50100% CALT

Portfolio after 10yr

$36.1K

Annual income

$1,637.90/yr

Blended yield

4.53%

📊

Analyst Conviction Gap

Where Wall Street is split right now

CALT

Analyst Ratings

Hold

Consensus: Hold

Price Target

$39.50

-1.3% upside vs current

Range: $39.00 — $40.00

Altman Z

8.0

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CALT buys

RYLD buys

No recent congressional trades found for CALT or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCALTRYLD

Forward yield	5.00%	12.14% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$27.8K	$44.5K ✓
Annual income after 10y	$688.45	$2,587.35 ✓
Total dividends collected	$6.0K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CALT vs RYLD ($10,000, DRIP)

Year	CALT Portfolio	CALT Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,200	$500.00	$11,914	$1,213.65	$714.00 → RYLD
2	$12,507	$523.36	$14,099	$1,351.30	$1.6K → RYLD
3	$13,929	$546.22	$16,580	$1,494.55	$2.7K → RYLD
4	$15,473	$568.51	$19,384	$1,642.61	$3.9K → RYLD
5	$17,146	$590.20	$22,535	$1,794.70	$5.4K → RYLD
6	$18,957	$611.24	$26,063	$1,950.00	$7.1K → RYLD
7	$20,916	$631.60	$29,995	$2,107.69	$9.1K → RYLD
8	$23,031	$651.27	$34,361	$2,266.99	$11.3K → RYLD
9	$25,314	$670.22	$39,194	$2,427.12	$13.9K → RYLD
10	$27,774	$688.45	$44,525	$2,587.35	$16.8K → RYLD

CALT vs RYLD: Complete Analysis 2026

CALT — Stock

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.

Full CALT Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this CALT vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CALT vs SCHD CALT vs JEPI CALT vs O CALT vs KO CALT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.